Asthma and COPD: Two Different Ways the Airways Can Narrow

Asthma is not always fully reversible, and COPD does not always worsen steadily. Diagnosis combines the symptom pattern, exposure pattern and objective tests. Treatment can reduce symptoms and future attacks in both conditions.

Similar symptoms do not establish the same disease Asthma and chronic obstructive pulmonary disease, called COPD, can both cause wheeze, cough, chest tightness and breathlessness. These symptoms are non specific. Heart disease, infection, bronchiectasis, anaemia, deconditioning and other conditions can produce similar experiences. Asthma and COPD can also both cause airflow obstruction, which means reduced airflow out of the lungs. However, their usual biological patterns differ. The distinction is clinically useful, but it is not a perfect reversible versus irreversible divide. Asthma usually causes variable symptoms and airflow Asthma is a chronic respiratory disease with several biological patterns. It usually involves chronic airway inflammation and variable expiratory airflow. During symptoms, bronchoconstriction tightens the smooth muscle surrounding the airways. Airway wall swelling and increased mucus can narrow them further. Symptoms often vary over time and may worsen at night, during viral infections, with exercise or after particular exposures. Some people have long symptom free periods. Others have frequent symptoms, severe exacerbations or persistent airflow obstruction despite treatment. A normal examination or breathing test on one day does not exclude asthma. Variability may need to be demonstrated at another time or with another objective test. COPD causes persistent airflow obstruction COPD is a heterogeneous lung condition involving chronic respiratory symptoms and persistent airflow obstruction. The obstruction results from differing combinations of small airway disease and alveolar damage. Emphysema means damage to the lung's air sacs and supporting elastic tissue. Tobacco smoking is the main cause in the United Kingdom, but COPD can affect people who have never smoked. Long term exposure to dust, fumes or air pollution can contribute. Rarely, inherited alpha 1 antitrypsin deficiency increases susceptibility. COPD airflow obstruction is often progressive, but the course is not always a steady decline. Symptoms, exacerbations and lung function change vary between people. Treatment cannot restore all structural damage. It can still improve symptoms, exercise capacity, quality of life and exacerbation risk. Reversibility is evidence, not a binary rule A bronchodilator is a medicine that relaxes airway smooth muscle and can increase airflow. A clear improvement after a bronchodilator can support asthma when the symptom pattern fits. However, a small or absent response on one occasion does not exclude asthma. People with COPD can also improve after a bronchodilator. The improvement may be clinically important even when airflow obstruction remains. Asthma can become associated with persistent airflow obstruction after many years. COPD can show day to day variation and a measurable bronchodilator response. Clinicians therefore do not classify the conditions from one before and after breathing test alone. Both conditions can have acute exacerbations An exacerbation is a worsening beyond the person's usual day to day variation. It can develop suddenly or over several days. Asthma exacerbations are often called asthma attacks. Viral infection, allergens, smoke, pollution or inadequate anti inflammatory treatment can contribute. COPD exacerbations commonly involve increased breathlessness, cough or sputum change. Infection, pollution and other triggers are possible, but no cause is found in every episode. An exacerbation does not automatically prove permanent disease progression. Recovery can be complete, partial or prolonged. New or unusually severe breathlessness should not automatically be attributed to the known lung condition. Pneumonia, pulmonary embolism, heart failure and pneumothorax may need consideration. Diagnosis uses the pattern and objective evidence Asthma diagnosis requires a symptom pattern suggesting asthma and supporting objective evidence. NICE advises against confirming asthma from symptoms alone. Current adult tests can include blood eosinophils, fractional exhaled nitric oxide, called FeNO, spirometry, peak flow variability and bronchial challenge testing. Spirometry measures how much air you can forcefully breathe out and how quickly. Different results answer different diagnostic questions. COPD is suspected from persistent symptoms and relevant exposures. Quality assured post bronchodilator spirometry supports and confirms persistent airflow obstruction in the appropriate clinical setting. A low FEV1/FVC ratio means that the amount exhaled in the first second is reduced compared with the full forced breath. That ratio must still be interpreted with age, symptoms, test quality and alternative diagnoses. Spirometry does not identify every cause of breathlessness. When features of asthma and COPD coexist, clinicians assess each feature rather than assuming one standard overlap disease. Specialist review may be needed when uncertainty remains. Treatment priorities overlap but are not identical Asthma treatment includes an inhaled corticosteroid to reduce airway inflammation and future attacks. The exact inhaler and schedule depend on age and current guidance. A reliever only approach without inhaled corticosteroid is no longer recommended for most people with asthma. COPD treatment often uses bronchodilators to reduce breathlessness and improve activity. Inhaled corticosteroids are added selectively according to exacerbations and features suggesting likely benefit. For people with COPD who smoke, stopping smoking is the most important step to reduce ongoing lung injury. Pulmonary rehabilitation combines supervised exercise, education and wider support. It can improve function and independence despite persistent structural lung changes. Vaccination, inhaler technique, physical activity and personalised action plans also matter. Treatment should address the person's symptoms, exacerbation risk and priorities. An adult with features of both conditions A 58 year old adult reports exertional breathlessness, intermittent wheeze and a morning cough. They smoked for twenty five years and had eczema and episodic wheeze when younger. The past or current smoking raises the probability of COPD but does not establish it. Childhood variability and eczema support asthma but do not confirm it. The clinician reviews symptom timing, triggers, sputum, infections, occupational exposures and treatment response. They also consider cardiac and other respiratory causes. Spirometry shows persistent airflow obstruction after bronchodilator treatment. FeNO is raised, and earlier records show substantial symptom and peak flow variability. These findings support COPD with clinically important asthma features. The clinician avoids reducing the case to one label and ensures that treatment includes inhaled corticosteroid because asthma is present. When urgent help is needed Call 999 during an asthma attack if symptoms worsen at any time, the maximum reliever dose does not help, or no inhaler is available. Call 999 for severe breathing difficulty, inability to speak normally, blue or grey lips or skin, sudden confusion, chest pain or collapse. Seek urgent clinical advice when COPD symptoms worsen beyond the personal action plan, especially with marked breathlessness, drowsiness or reduced ability to manage at home. This lesson explains general differences between asthma and COPD. It cannot diagnose the cause of wheeze or breathlessness or select an inhaler for you.

Asthma usually involves variable symptoms and airflow, while COPD causes persistent airflow obstruction through differing airway and alveolar changes. Neither condition follows one universal course, and one reversibility test does not distinguish them reliably.